| |
Reed's,
Inc. Exhibits at American Society of Clinical Oncology (ASCO) 2009 Annual
Meeting
Study findings released showing ginger provides significant
reduction of chemotherapy-induced nausea
LOS ANGELES, June 2, 2009 (MARKETWIRE) -- Reed's, Inc. (NASDAQ: REED), maker
of the top-selling sodas in natural food stores nationwide, announced today
that it exhibited at the ASCO
2009 Annual Meeting. Founded in 1964, the American
Society of Clinical Oncology (ASCO) is the world’s leading professional
organization representing physicians who treat people with cancer. ASCO released
the official findings of a study funded by the National
Cancer Institute on the effects
of ginger on post-chemo nausea at the meeting.
The ASCO Annual Meeting is considered the premier educational and scientific
event in the oncology community. More than 26,000 professionals attended the
educational and scientific sessions that offered cutting-edge information
on the diagnosis and treatment of patients with cancer.
“It was exciting to be there alongside companies that provide cancer
treatments and support services,” stated Mr. Chris Reed, Founder and
CEO of Reed’s, Inc. “The original intent of this company was to
be able to help people by providing a ginger tonic disguised as a soft drink.
It’s great to get validation from the medical industry on the effectiveness
of ginger in treating nausea. I’m pretty sure we’re the first
soft drink company to find our all-natural main ingredient competing with
drugs.”
Reed added, “It’s nice to be valued as more than just a fun,
thirst-quenching beverage company. Ginger has many other traditional uses
and seems to be attracting more and more research. I have seen numerous studies
around ginger and its cancer-fighting properties; I have seen medical studies
where ginger beats Dramamine, a popular motion sickness drug. In Europe, they
use ginger for arthritis due to its anti-inflammatory properties. I hear from
customers that are using it to relieve migraines and other inflammation conditions.
Ginger is one folk medicine that seems to hold up to medical scrutiny.”
“We get a pretty steady stream of people emailing to tell us how well
our drinks work in helping them overcome nausea and digestive complaints and
particularly post-chemo nausea. We will continue to expand on the many contacts
we have received at this show to help promote our drink’s benefits to
the oncology industry,” concluded Reed.
About Reed's, Inc.
Reed's, Inc. makes the top selling sodas in natural food markets nationwide
and is currently selling in 10,500 supermarkets in natural foods and mainstream.
Its six award-winning non-alcoholic Ginger Brews are unique in the beverage
industry, being brewed, not manufactured and using fresh ginger, spices and
fruits in a brewing process that predates commercial soft drinks. In addition,
the Company owns the top selling root beer line in natural foods, the Virgil's
Root Beer product line, and the top selling cola line in natural foods, the
China Cola product line. Other product lines include: Reed's Ginger Candies
and Reed's Ginger Ice Creams.
Reed's products are sold through specialty gourmet and natural food stores,
mainstream supermarket chains, retail stores and restaurants nationwide, and
in Canada. For more information about Reed's,
please visit the company's website at: http://www.reedsgingerbrew.com
or call 800-99-REEDS.
Follow Reed’s on Twitter at: http://www.twitter.com/reedsgingerbrew
View Reed’s YouTube channel at: http://www.youtube.com/reedsgingerbrew
Review Reed’s Delicious bookmarks at: http://www.delicious.com/reedsinc
Join Reed’s Facebook Fan Page at: http://www.facebook.com/pages/Reeds-Ginger-Brew-and-Virgils-Natural-Sodas/57143529039?ref=nf
Subscribe to Reed’s RSS feed at: http://www.irthcommunications.com/REED_rss.xml
More information can be found at: http://www.irthcommunications.com/clients_REED.php
SAFE HARBOR STATEMENT
Some portions of this press release, particularly those describing Reed's
goals and strategies, contain ``forward-looking statements.'' These forward-looking
statements can generally be identified as such because the context of the
statement will include words, such as ``expects,'' ``should,'' ``believes,''
``anticipates'' or words of similar import. Similarly, statements that describe
future plans, objectives or goals are also forward-looking statements. While
Reed's is working to achieve those goals and strategies, actual results could
differ materially from those projected in the forward-looking statements as
a result of a number of risks and uncertainties. These risks and uncertainties
include difficulty in marketing its products and services, maintaining and
protecting brand recognition, the need for significant capital, dependence
on third party distributors, dependence on third party brewers, increasing
costs of fuel and freight, protection of intellectual property, competition
and other factors, any of which could have an adverse effect on the business
plans of Reed's, its reputation in the industry or its expected financial
return from operations and results of operations. In light of significant
risks and uncertainties inherent in forward-looking statements included herein,
the inclusion of such statements should not be regarded as a representation
by Reed's that they will achieve such forward-looking statements. For further
details and a discussion of these and other risks and uncertainties, please
see our most recent reports on Form 10-KSB and Form 10-Q, as filed with the
Securities and Exchange Commission, as they may be amended from time to time.
Reed's undertakes no obligation to publicly update any forward-looking statement,
whether as a result of new information, future events, or otherwise.
Source: Reed’s, Inc.
Contact
IRTH Communications, LLC
Mark B. Moline
Managing Partner
760-458-4899
mark@irthcommunications.com
http://www.irthcommunications.com
http://www.twitter.com/irthcomm
|
